Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
28,800.00 Euro
Forbid offers above base price:
Request Reference:
AM/00000003/2023
Request Name:
AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUBAB VEDOTINA 20 MG
Phase:
Tendering Phase
State:
Awarded
Description:
AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUBAB VEDOTINA 20 MG
Procedure Type:
VortalGOV - Direct Award (ECP)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
A17 AVEIRO Aveiro PORTUGAL
CPV Main Vocabulary
33652000-5 - Antineoplastic and immunomodulating agents
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
9/11/2023 12:07 PM
(UTC +1 hour)
Due datetime for receiving replies:
9/14/2023 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
CE AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUMAB VEDOTINA 20 MG_AM32023_signed_signed.pdf
CE AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUMAB VEDOTINA 20 MG_AM32023_signed_signed.pdf
Download
Convite AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUMAB VEDOTINA 20 MG_AM32023_v1_signed_signed.pdf
Convite AQUISIÇÃO DE MEDICAMENTO EXCLUSIVO ASTELLAS - ENFORTUMAB VEDOTINA 20 MG_AM32023_v1_signed_signed.pdf
Download
AM000000032023-9800313 - ASTELLAS FARMA,LDA.xlsx
AM000000032023-9800313 - ASTELLAS FARMA,LDA.xlsx
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
110138964 Enfortumab vedotina 20 mg Pó conc sol inj Fr IV
*
(Os valores indicados não incluem o IVA)
Preço Total
Total without VAT
0,00
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
110138964
Internal Reference
Description
Enfortumab vedotina 20 mg Pó conc sol inj Fr IV
Qty
48,000000
Unit
F.A
Price per Unit
Total
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
LowestPrice
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Critérios da Avaliação
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...